India, Jan. 13 -- Caplin Point Laboratories built its foundation by venturing where few dared: the "Bottom of the Pyramid" markets of Latin America and Francophone Africa. By removing intermediaries and owning last-mile distribution, the company transformed affordability into a strategic fortress. Today, this fully integrated innovator is using that resilience to bridge the gap to the West. Through Caplin Steriles, it has successfully entered the US and EU, focusing on high-barrier injectables and ophthalmics. With over 5,000 registrations and a 15-year track record of profitable growth, Caplin is now accelerating its expansion into Canada, Australia, and major Latin American economies like Brazil and Mexico.

Decade of Fiscal Discipline ...